Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Recovery International, 1% Increase in Ordinary Profit, Update Record High for Eighth Consecutive Term
9214 Recovery International Co.,Ltd. 【J-GAAP】
Earnings ReportRecovery International Co.,Ltd. <9214> [TSE Growth] announced its financial results after the market closed on February 12th (15:30). The ordinary profit (non-consolidated) for the fiscal year ending December 2024 expanded 31.4% from the previous period to 201 million yen. In the fiscal year ending December 2025, the profit is expected to grow by 1.5% to 204 million yen, marking the eighth consecutive term of record-high profits. This will be the ninth consecutive term of revenue and the fifth consecutive term of profit growth.
In the most recent three-month period, from October to December (4Q), the ordinary profit increased 97.5% from the same period last year, reaching 79 million yen. The operating profit margin improved from 9.1% in the same period last year to 11.5%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2022 | 1,385 | 154 | 149 | 108 | 78.4 | 0 | Feb 13, 2023 | J-GAAP |
Dec, 2023 | 1,605 | 150 | 153 | 110 | 77.9 | 0 | Feb 14, 2024 | J-GAAP |
Dec, 2024 | 2,043 | 180 | 201 | 145 | 105.1 | 0 | Feb 12, 2025 | J-GAAP |
YoY | +27.3% | +20.0% | +31.4% | +31.8% | +34.9% |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2024 Guidance | 1,980 | 178 | 195 | 131 | 96.8 | 0 | Feb 14, 2024 | J-GAAP |
Dec, 2024 Results | 2,043 | 180 | 201 | 145 | 105.1 | 0 | Feb 12, 2025 | J-GAAP |
Revision Rate | +3.2% | +1.1% | +3.1% | +10.7% | +8.6% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Jun, 2024 | 929 | 45 | 48 | 30 | 21.6 | 0 | Aug 14, 2024 | J-GAAP |
Jan - Jun, 2025 Guidance | ー | ー | ー | ー | - | 0 | Feb 12, 2025 | J-GAAP |
YoY | - | - | - | - | - |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2023 | 1,605 | 150 | 153 | 110 | 77.9 | 0 | Feb 14, 2024 | J-GAAP |
Dec, 2024 | 2,043 | 180 | 201 | 145 | 105.1 | 0 | Feb 12, 2025 | J-GAAP |
Dec, 2025 Guidance | 2,532 | 201 | 204 | 136 | 99.0 | 0 | Feb 12, 2025 | J-GAAP |
YoY | +23.9% | +11.7% | +1.5% | -6.2% | -5.8% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 430 | 39 | 40 | 36 | 25.5 | 9.1 | Feb 14, 2024 | J-GAAP |
Jan - Mar, 2024 | 441 | 40 | 40 | 26 | 18.7 | 9.1 | May 15, 2024 | J-GAAP |
Apr - Jun, 2024 | 488 | 5 | 8 | 4 | 2.9 | 1.0 | Aug 14, 2024 | J-GAAP |
Jul - Sep, 2024 | 539 | 69 | 74 | 50 | 36.0 | 12.8 | Nov 13, 2024 | J-GAAP |
Oct - Dec, 2024 | 575 | 66 | 79 | 65 | 47.1 | 11.5 | Feb 12, 2025 | J-GAAP |
YoY | +33.7% | +69.2% | +97.5% | +80.6% | +84.7% |
Related Articles
PCI Holdings, Oct-Dec (1Q) Ordinary Profit Increases by 67%
Japan Display, The Current Fiscal Year Net Income Loss Widened in Downward Revision, 72% Deficit Against Net Assets
eREX, Oct-Dec (3Q) Net Income Turns to Profit, The Undetermined Dividend Set at 11 yen, Resuming Dividends for the First Time in Two Terms
Photosynth, 76% Increase in Ordinary Profit, Update Record High for Second Consecutive Term
I-ne, 8% Increase in Ordinary Profit, Update Record High for Eighth Consecutive Term, Dividend Raised by 0.5 yen
FUSO DENTSU, Oct-Dec (1Q) Ordinary Profit Decreases by 6%
C.I. MEDICAL, 63% Increase in Ordinary Profit for The Current Fiscal Year
Kubota Pharma, Last Fiscal Year's Undisclosed Net Income to Narrow
Moriya Transportation Engineering, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 60%, Oct-Dec Ordinary Profit Increases by 54%
ExaWizards, Apr-Dec (Cumulative 3Q) Ordinary Profit Loss Narrows, Oct-Dec Ordinary Profit Turns to Profit